These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10048882)

  • 1. Neuromuscular blockade in the intensive care unit.
    Lewis KS; Rothenberg DM
    Am J Health Syst Pharm; 1999 Jan; 56(1):72-5. PubMed ID: 10048882
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence?
    Puthucheary Z; Rawal J; Ratnayake G; Harridge S; Montgomery H; Hart N
    Am J Respir Crit Care Med; 2012 May; 185(9):911-7. PubMed ID: 22550208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical care myopathy in a child.
    Newman AJ; Singer NG
    J Clin Rheumatol; 2005 Apr; 11(2):93-7. PubMed ID: 16357710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual neuromuscular blockade in critical care.
    Wilson J; Collins AS; Rowan BO
    Crit Care Nurse; 2012 Jun; 32(3):e1-9; quiz e10. PubMed ID: 22661165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two identical episodes of acute quadriparesia in an intensive care unit patient.
    Kohler A; Jolliet P; Schnorf H; Magistris MR
    Intensive Care Med; 1998 Aug; 24(8):891-2. PubMed ID: 9757940
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiological changes of the neuromuscular transmission in the critically ill patient.
    Khuenl-Brady KS
    Acta Anaesthesiol Scand Suppl; 1997; 111():108. PubMed ID: 9420975
    [No Abstract]   [Full Text] [Related]  

  • 7. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period.
    Murphy GS
    Minerva Anestesiol; 2006 Mar; 72(3):97-109. PubMed ID: 16493386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit.
    Durbin CG
    Crit Care Clin; 1991 Jul; 7(3):489-506. PubMed ID: 1863878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review.
    Wilcox SR
    J Crit Care; 2017 Feb; 37():149-155. PubMed ID: 27736708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodialysis as treatment for prolonged neuromuscular blockade in anephric patients.
    Lavine LM; Hindin BI
    Anesthesiology; 1983 Sep; 59(3):264-5. PubMed ID: 6881601
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle weakness and difficulty in weaning from the ventilator in the critical care unit.
    Bolton CF
    Chest; 1994 Jul; 106(1):1-2. PubMed ID: 8020252
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromuscular blocking agents in the intensive care unit: a two-edged sword.
    Khuenl-Brady KS; Sparr HJ; Waibel U
    Crit Care Med; 1996 Apr; 24(4):717-9. PubMed ID: 8612428
    [No Abstract]   [Full Text] [Related]  

  • 14. Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade.
    Corso L
    Crit Care Nurse; 2008 Jun; 28(3):30-8; quiz 39. PubMed ID: 18515606
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects.
    Lacomis D; Giuliani MJ; Van Cott A; Kramer DJ
    Ann Neurol; 1996 Oct; 40(4):645-54. PubMed ID: 8871585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive care unit-acquired weakness: risk factors and prevention.
    de Jonghe B; Lacherade JC; Sharshar T; Outin H
    Crit Care Med; 2009 Oct; 37(10 Suppl):S309-15. PubMed ID: 20046115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should respiratory therapists routinely monitor neuromuscular blockade in the intensive care unit?
    Jelacic S; Bowdle A; Bussey L; Nguyen S; Ocol JM; Togashi K
    J Clin Anesth; 2024 Feb; 92():111310. PubMed ID: 37918081
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromuscular blocking drugs in the intensive care unit: introductory remarks.
    Bion JF; Pollard BJ
    Intensive Care Med; 1993; 19 Suppl 2():S35. PubMed ID: 8106675
    [No Abstract]   [Full Text] [Related]  

  • 19. End-Plate Disorders in Intensive Care Unit.
    Camdessanché JP
    J Clin Neurophysiol; 2020 May; 37(3):211-213. PubMed ID: 32358248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the duration of anesthesia on neuromuscular potency.
    Kopman AF
    Anesthesiology; 2003 May; 98(5):1300; author reply 1300-1. PubMed ID: 12717164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.